Literature DB >> 28939147

Cardiac Dysfunction Caused by Osimertinib.

Takuya Oyakawa1, Kazuhisa Nakashima2, Tateaki Naito2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28939147     DOI： 10.1016/j.jtho.2017.05.016

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  6 in total

Review 1.  Aumolertinib Effectively Reduces Clinical Symptoms of an EGFR L858R-Mutant Non-Small Cell Lung Cancer Case Coupled With Osimertinib-Induced Cardiotoxicity: Case Report and Review.

Authors:  Qianqian Zhang; Haiyang Liu; Jia Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-23       Impact factor: 6.055

2.  Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib.

Authors:  Kei Kunimasa; Risa Kamada; Toru Oka; Makiko Oboshi; Madoka Kimura; Takako Inoue; Motohiro Tamiya; Tatsuya Nishikawa; Taku Yasui; Wataru Shioyama; Kazumi Nishino; Fumio Imamura; Toru Kumagai; Masashi Fujita
Journal:  JACC CardioOncol       Date:  2020-03-17

Review 3.  Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer.

Authors:  Magdalena Zaborowska-Szmit; Maciej Krzakowski; Dariusz M Kowalski; Sebastian Szmit
Journal:  J Clin Med       Date:  2020-04-27       Impact factor: 4.241

4.  Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS).

Authors:  Kartik Anand; Joe Ensor; Barry Trachtenberg; Eric H Bernicker
Journal:  JACC CardioOncol       Date:  2019-12-17

5.  Fulminant myocarditis in a patient with a lung adenocarcinoma after the third dose of modern COVID-19 vaccine. A case report and literature review.

Authors:  Eduardo Terán Brage; Jonnathan Roldán Ruíz; Javier González Martín; Juan Diego Oviedo Rodríguez; Rosario Vidal Tocino; Sara Rodríguez Diego; Pedro Luis Sánchez Hernández; Lorena Bellido Hernández; Emilio Fonseca Sánchez
Journal:  Curr Probl Cancer Case Rep       Date:  2022-03-31

6.  Osimertinib induced cardiomyopathy: A case report.

Authors:  Shun Shinomiya; Kyoichi Kaira; Ou Yamaguchi; Keitaro Ishikawa; Hiroshi Kagamu
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.